Who owns the NEW YORK CANCER & BLOOD SPECIALISTS trademark?

The NEW YORK CANCER & BLOOD SPECIALISTS trademark is owned by North Shore Hematology Oncology Associates, PC.

What class is the NEW YORK CANCER & BLOOD SPECIALISTS trademark registered in?

The NEW YORK CANCER & BLOOD SPECIALISTS trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for NEW YORK CANCER & BLOOD SPECIALISTS?

The USPTO serial number for NEW YORK CANCER & BLOOD SPECIALISTS is 87688894.

What is the registration number for NEW YORK CANCER & BLOOD SPECIALISTS?

NEW YORK CANCER & BLOOD SPECIALISTS is registered under USPTO registration number 5517911.

NEW

USPTO Trademark Record

REGISTERED

NEW YORK CANCER & BLOOD SPECIALISTS

SN 87688894·Reg 5517911·Filed Nov 17, 2017

Owner North Shore Hematology Oncology Associates, PC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

NEW YORK CANCER & BLOOD SPECIALISTS (Serial No. 87688894), Registration No. 5517911, is a registered US trademark filed on Nov 17, 2017 by North Shore Hematology Oncology Associates, PC. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

Section 8/9 declaration window: July 17, 2028

Mark Intelligence

NEW YORK CANCER & BLOOD SPECIALISTS (Reg. #5517911) is a registered US trademark that has been protecting its owner, North Shore Hematology Oncology Associates, PC, since 2017. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 17, 2017

SERIAL

87688894

REG#

5517911

REGISTERED

Jul 17, 2018

Owner

Applicant

North Shore Hematology Oncology Associates, PC

Entity

Corporation

State

Address

235 N. Belle Mead Rd., East Setauket, NY, 11733

Country

Attorney

NameStephen R. Barrese, Esq.

Law firm

Stephen R. Barrese, Esq. DILWORTH & BARRESE, LLP

Docket

1713-7

Address

1000 WOODBURY ROAD, SUITE 405, WOODBURY, NY 11797, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateNov 17, 2017

Serial Number87688894

Registration No.5517911

Registration DateJul 17, 2018

Status DateDec 20, 2024

Published for OppositionMay 01, 2018

Next RenewalJuly 17, 2028

Mark TypeDesign with words

Attorney Docket1713-7

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 30, 2011

First use in commerce: Jun 30, 2011

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Jun 30, 2011

First use in commerce: Jun 30, 2011

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Dec 20, 2024

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Dec 20, 2024

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 20, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

Jul 22, 2024

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 17, 2023

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Jul 17, 2018

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

May 01, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 01, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 11, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Mar 26, 2018

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 17, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 17, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 16, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 16, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Mar 12, 2018

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 12, 2018

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 12, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 02, 2018

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Dec 01, 2017

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 30, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 21, 2017

NEW APPLICATION ENTERED

NEW YORK CANCER & BLOOD SPECIALISTS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by North Shore Hematology Oncology Associates, PC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Stephen R. Barrese, Esq.

Resources

Company